DK1228708T4 - Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk - Google Patents

Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Info

Publication number
DK1228708T4
DK1228708T4 DK02000982T DK02000982T DK1228708T4 DK 1228708 T4 DK1228708 T4 DK 1228708T4 DK 02000982 T DK02000982 T DK 02000982T DK 02000982 T DK02000982 T DK 02000982T DK 1228708 T4 DK1228708 T4 DK 1228708T4
Authority
DK
Denmark
Prior art keywords
milk
blood pressure
high blood
protein fraction
basic protein
Prior art date
Application number
DK02000982T
Other languages
Danish (da)
English (en)
Other versions
DK1228708T3 (da
Inventor
Toba Yasuhiro
Takada Yukihiro
Morita Yoshikazu
Abe Takumi
Kawakami Hiroshi
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26607795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1228708(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP2001008189A external-priority patent/JP4034516B2/ja
Priority claimed from JP2001008190A external-priority patent/JP4028177B2/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of DK1228708T3 publication Critical patent/DK1228708T3/da
Application granted granted Critical
Publication of DK1228708T4 publication Critical patent/DK1228708T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/268—Hydrolysates from proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A21D2/263—Animal proteins from dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DK02000982T 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk DK1228708T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001008189A JP4034516B2 (ja) 2001-01-16 2001-01-16 脂質代謝改善剤
JP2001008190A JP4028177B2 (ja) 2001-01-16 2001-01-16 血圧降下剤

Publications (2)

Publication Number Publication Date
DK1228708T3 DK1228708T3 (da) 2004-07-05
DK1228708T4 true DK1228708T4 (da) 2008-01-07

Family

ID=26607795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02000982T DK1228708T4 (da) 2001-01-16 2002-01-16 Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk

Country Status (7)

Country Link
US (2) US20030040475A1 (de)
EP (1) EP1228708B2 (de)
AT (1) ATE261669T1 (de)
DE (1) DE60200256T3 (de)
DK (1) DK1228708T4 (de)
ES (1) ES2215940T5 (de)
PT (1) PT1228708E (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
NZ513305A (en) * 1999-01-11 2003-06-30 Calpis Co High yield production of curds and whey containing an ACE inhibitor peptide (val-pro-pro and/or ile-pro-pro) made under stirring conditions
JP4633876B2 (ja) 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
JP2002193817A (ja) * 2000-12-28 2002-07-10 Calpis Co Ltd 整腸剤
US20050020484A1 (en) * 2001-12-28 2005-01-27 Etsumori Harada Compositions for improving lipid metabolism
WO2005074968A2 (en) * 2004-02-10 2005-08-18 Universiteit Maastricht Medical use of basic peptides
EP1685764A1 (de) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Funktionelle Lebensmittelprodukte mit blutdrucksenkender Wirkung
TW200605902A (en) * 2004-08-05 2006-02-16 Maxluck Biotechnology Corp Composition for lowering blood lipid
EP1930017B1 (de) * 2005-09-29 2012-05-23 Maruha Nichiro Seafoods, Inc. Zusammensetzung zur prävention und behandlung von krankheiten von erwachsenen
WO2008111573A1 (ja) * 2007-03-12 2008-09-18 Snow Brand Milk Products Co., Ltd. 成長ホルモン分泌促進剤
WO2009034325A1 (en) * 2007-09-14 2009-03-19 Cammedica Limited Isoflavone formulation
FI122252B (fi) * 2008-01-04 2011-10-31 Valio Oy Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
US20110165138A1 (en) * 2008-06-26 2011-07-07 Healthlinx Limited Protocols for treating and preventing obesity and complications arising therefrom
US20130058898A1 (en) * 2010-03-10 2013-03-07 Kaneka Corporation Lactic acid bacterium-containing preparation
MY162943A (en) 2011-01-26 2017-07-31 Megmilk Snow Brand Co Ltd Sense-improving agent
EP2741757B1 (de) 2011-09-11 2018-05-16 Minovia Therapeutics Ltd. Zusammensetzungen aus funktionellen mitochondrien und ihre verwendungen
JP6309202B2 (ja) * 2013-03-28 2018-04-11 雪印メグミルク株式会社 タンパク質組成物およびその製造方法
JP6395350B2 (ja) * 2013-03-28 2018-09-26 雪印メグミルク株式会社 筋萎縮防止剤
US11951135B2 (en) 2018-07-22 2024-04-09 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458818B (sv) † 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
CA2086681C (en) * 1990-07-13 2004-01-06 Francis J. Ballard Growth promoting agent derived from milk
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
JP2944008B2 (ja) * 1990-09-20 1999-08-30 森永乳業株式会社 非経口脂質代謝改善剤
JP2974604B2 (ja) † 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4082782B2 (ja) * 1998-04-30 2008-04-30 雪印乳業株式会社 歯周病予防及び改善剤
US6649590B2 (en) * 2000-06-09 2003-11-18 Snow Brand Milk Products Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof

Also Published As

Publication number Publication date
US20030040475A1 (en) 2003-02-27
DK1228708T3 (da) 2004-07-05
ATE261669T1 (de) 2004-04-15
DE60200256T3 (de) 2008-04-03
ES2215940T3 (es) 2004-10-16
ES2215940T5 (es) 2008-03-16
EP1228708A2 (de) 2002-08-07
PT1228708E (pt) 2004-05-31
DE60200256T2 (de) 2005-03-03
DE60200256D1 (de) 2004-04-22
EP1228708A3 (de) 2002-08-14
EP1228708B1 (de) 2004-03-17
EP1228708B2 (de) 2007-08-22
US20040167078A1 (en) 2004-08-26
US6929806B2 (en) 2005-08-16

Similar Documents

Publication Publication Date Title
DK1228708T3 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
WO2007029238A3 (en) Methods and compositions for oral administration of proteins
CY1110547T1 (el) Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
WO2007011874A3 (en) Formulation and method for administration of ophthalmologically active agents
DE602005026031D1 (de) Kristalline formen von (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
NO20054555D0 (no) Farmasoytiske preparater som omfatter syrestabilisert insulin
ECSP088962A (es) Nuevos herbicidas
BRPI0516577A (pt) agentes terapêuticos com toxicidade diminuìda
EA200800337A1 (ru) Композиция и способ введения офтальмологически активных средств
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
DK1492761T3 (da) Aminosyrer med affinitet til alpha-2-delta-proteinet
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
WO2004006756A3 (en) THERAPIES FOR RENAL FAILURE USING INTERFERON-β
WO2006077427A3 (en) Antiviral drug combinations
NO20054440L (no) Flytende formuleringer av tumornekrosefaktorbindende proteiner
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
NO20030231D0 (no) Proteinkompleks som fungerer som en vehikkel for oralt administrerbare medikamenter
EA200701072A1 (ru) Препараты бензотиазола и их применение
EA200500764A1 (ru) Фармацевтические композиции и лекарственные формы для трансбуккальной и сублингвальной доставки тизанидина и способы введения тизанидина сублингвально или трансбуккально
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
ATE361068T1 (de) Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
ATE305796T1 (de) Präparationen von vitamin e in kombination mit afamin